1-18 of 18
Christian Gerecke
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-Term Outcome of a Prospective Randomized Trial Comparing Continuous Lenalidomide/Dexamethasone with Lenalidomide/Dexamethasone Induction, MEL140 with Autologous Blood Stem Cell Transplantation and Single Agent Lenalidomide Maintenance in Patients of Age 60-75 Years with Newly Diagnosed Multiple Myeloma

Free
Christian Straka, Kerstin Schaefer-Eckart, Bernd Hertenstein, Florian Bassermann, Hans Salwender, Christian Langer, Jan Krönke, Miriam Kull, Georgia Schilling, Aneta Schieferdecker, Monika Engelhardt, Stefan Knop, Julia Reusch, Wolf Roesler, Bernd Metzner, Holger Hebart, Albrecht Reichle, Matthias Grube, Norbert Frickhofen, Christian Gerecke, Stephan Fuhrmann, Wolfram Jung, Martin Gramatzki, Thomas Decker, Tobias Dechow, Jochen Greiner, Tim H. Brümmendorf, Juliana Ababei, Ivana von Metzler, Ralph Naumann, Elisabeth Fritz, Marcus Hentrich, Peter Bojko, Thomas Kubin, Christian Schmidt, Martin Kaufmann, Burkhard Schmidt, Axel Hinke, Hermann Einsele
Journal: Blood
Blood (2022) 140 (Supplement 1): 287–288.
https://doi.org/10.1182/blood-2022-159357
Published: 2022
Journal Articles

Response-Adapted Lenalidomide Maintenance in Newly Diagnosed, Transplant-Eligible Multiple Myeloma: Results from the Multicenter Phase III GMMG-MM5 Trial

Free
Hartmut Goldschmidt, MD, Elias K Mai, MD, Jan Dürig, MD, Christof Scheid, MD, Katja C. Weisel, Christina Kunz, Uta Bertsch, MD, Thomas Hielscher, PhD, Markus Munder, MD, Hans-Walter Lindemann, Barbara Huegle-Doerr, Dirk Hose, MD, Anja Seckinger, Stefanie Huhn, PhD, Anna Jauch, Bernhard Rabold, Ahmet Elmaagacli, MD, Christian Gerecke, MD, Peter Brossart, MD, Martin Goerner, MD, Helga Bernhard, MD, Martin Hoffmann, MD, Jens Hillengass, MD, Marc-Steffen S Raab, Igor Wolfgang Blau, MD, Mathias Hänel, MD, Hans Jürgen Salwender
Journal: Blood
Blood (2017) 130 (Supplement 1): 400.
https://doi.org/10.1182/blood.V130.Suppl_1.400.400
Published: 2017
Journal Articles

Direct Assessment of IgA and IgG Paraprotein By Hevylite Assay and Correlation to IMWG Response and Progression-Free Survival in Newly Diagnosed, Transplant-Eligible Multiple Myeloma Patients in the Prospective Phase III GMMG-MM5 Trial

Free
Christof Scheid, MD, Anja Seckinger, Jan Dürig, MD, Katja C. Weisel, Christina Kunz, Uta Bertsch, MD, Thomas Hielscher, PhD, Markus Munder, MD, Hans-Walter Lindemann, Barbara Huegle-Doerr, Stefanie Huhn, PhD, Elias K Mai, MD, Anna Jauch, Bernhard Rabold, Christian Gerecke, MD, Peter Brossart, MD, Martin Goerner, MD, Helga Bernhard, MD, Martin Hoffmann, MD, Jens Hillengass, MD, Marc-Steffen S Raab, Igor Wolfgang Blau, MD, Mathias Haenel, Dirk Hose, MD, Hartmut Goldschmidt, MD, Hans Jürgen Salwender
Journal: Blood
Blood (2017) 130 (Supplement 1): 1784.
https://doi.org/10.1182/blood.V130.Suppl_1.1784.1784
Published: 2017
Journal Articles

A Predictive Score for Early Mortality during Induction Therapy in Newly Diagnosed Transplant-Eligible Multiple Myeloma - an Analysis from Five GMMG and HOVON Multicenter Phase III Trials

Free
Elias K Mai, MD, Thomas Hielscher, PhD, Uta Bertsch, MD, Jana Schlenzka, MD, Hans Jürgen Salwender, Henk M Lokhorst, Markus Munder, MD, Bronno van der Holt, Christian Gerecke, MD, Michael Pfreundschuh, MD, Ulrich Duhrsen, Peter Brossart, MD, Sonja Zweegman, MD PhD, Kai Neben, Jens Hillengass, MD, Marc-Steffen S Raab, Dirk Hose, MD, Edo Vellenga, MD, Maximilian Merz, MD, Iris Breitkreutz, MD, Anna Jauch, Marie José Kersten, MD, Hans Martin, Hans-Walter Lindemann, Norma Peter, MD, Sandra Croockewit, MD, Igor Wolfgang Blau, MD, Christof Scheid, MD, Katja C. Weisel, Pieter Sonneveld, MDPhD, Hartmut Goldschmidt, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2016.
https://doi.org/10.1182/blood.V130.Suppl_1.2016.2016
Published: 2017
Journal Articles

Clinical Risk Factors for Peripheral Neuropathy in Patients Treated with Subcutaneous or Intravenous Bortezomib for Newly Diagnosed Multiple Myeloma

Free
Maximilian Merz, MD, Hans-Juergen Salwender, MD, Mathias Haenel, MD, Uta Bertsch, MD, Christina Kunz, Thomas Hielscher, Igor W. Blau, MD, Christof Scheid, MDPhD, Elias Karl Mai, MD, Dirk Hose, MD, Bärbel Schurich, Markus Munder, MD, Peter Brossart, MD, Christian Gerecke, MD, Hans Walter Lindemann, MD, Matthias Zeis, MD, Katja C. Weisel, Jan Duerig, MD, Hartmut Goldschmidt, MD
Journal: Blood
Blood (2015) 126 (23): 4233.
https://doi.org/10.1182/blood.V126.23.4233.4233
Published: 2015
Journal Articles

Influence of Renal Impairment and Genetic Risk Factors on Response to Induction Therapy in the HD4 and MM5 Trials of the GMMG

Free
Christof Scheid, MDPhD, Thomas Hielscher, Uta Bertsch, MD, Christina Kunz, PhD, Hans Salwender, MD, Mathias Haenel, Maximilian Merz, Elias Karl Mai, MD, Dirk Hose, MD PhD, Baerbel Schurich, PhD, Markus Munder, MD, Ingo Schmidt-Wolf, MD, Christian Gerecke, MD, Walter Lindemann, MD, Matthias Zeis, MD, Katja Weisel, MD, Jan Duerig, MD, Anna Jauch, PhD, Hartmut Goldschmidt, MD
Journal: Blood
Blood (2014) 124 (21): 4777.
https://doi.org/10.1182/blood.V124.21.4777.4777
Published: 2014
Journal Articles

Subcutaneous Versus Intravenous Bortezomib in Two Different Induction Therapies for Newly Diagnosed Multiple Myeloma – Subgroup Analysis from the GMMG-MM5 Trial

Free
Maximilian Merz, MD, Hans Salwender, MD, Mathias Hänel, MD, Uta Bertsch, MD, Christina Kunz, PhD, Thomas Hielscher, Igor W. Blau, MD, Christof Scheid, MDPhD, Elias Karl Mai, MD, Dirk Hose, MD, Baerbel Schurich, PhD, Markus Munder, MD, Ingo GH Schmidt-Wolf, MD, Christian Gerecke, MD, Hans Walter Lindemann, MD, Matthias Zeis, MD, Katja Weisel, MD, Jan Duerig, MD, Hartmut Goldschmidt, MD
Journal: Blood
Blood (2014) 124 (21): 3475.
https://doi.org/10.1182/blood.V124.21.3475.3475
Published: 2014
Journal Articles

Lenalidomide with Low-Dose Dexamethasone (Rd) Continuously Versus Rd Induction, Tandem MEL140 with Autologous Transplantation and Lenalidomide Maintenance: Planned Interim Analysis of a Prospective Randomized Trial in Patients 60-75 Years of Age with Multiple Myeloma

Free
Christian Straka, MD, Kerstin Schaefer-Eckart, MD, Florian Bassermann, MD, Hansen Timon, MD, Bernd Hertenstein, MD, Christian Langer, MD, Hans Salwender, MD, Stefan Knop, MD, Monika Engelhardt, MD, Martin Kropff, MD, Wolf Roesler, MD, Thomas Decker, MD, Holger Hebart, MD, Norbert Frickhofen, MD, Albrecht Reichle, Christian Gerecke, MD, Bernd Metzner, Else Heidemann, MD, Tim H Brummendorf, MD, Juliane Ababei, MD, Wolfram E Jung, MD, Martin Gramatzki, MD, Marcus Hentrich, MD, Peter Bojko, MD, Ivana von Metzler, MD, Martin Kaufmann, MD, Ralph Naumann, MD, Thomas Kubin, MD, Burkhard Schmidt, MD, Jochem Walther, MD, Tobias Dechow, MD, Hannes Wandt, MD, Brigitte Schnabel, Axel Hinke, PhD, Hermann Einsele
Journal: Blood
Blood (2014) 124 (21): 3969.
https://doi.org/10.1182/blood.V124.21.3969.3969
Published: 2014
Journal Articles

Prognostic Value Of sFLC Ratio At Baseline On Response After Induction Therapy In Patients With Multiple Myeloma In The GMMG MM5 Trial

Free
Mabast Moohialdin, Hans Salwender, MD, Uta Bertsch, MD, Jan Duerig, MD, Christina Kunz, PhD, Thomas Hielscher, Markus Zorn, Mathias Haenel, MD, Igor Wolfgang Blau, MD, PhD, Dirk Hose, Dr. med. dipl.-phys, Baerbel Schurich, PhD, Kai Neben, MD, Anja Seckinger, MD, Markus Munder, MD, Walter Lindemann, MD, Matthias Zeis, MD, Christian Gerecke, MD, Ingo GH Schmidt-Wolf, MD, Katja Weisel, MD, Christof Scheid, MD, Hartmut Goldschmidt, MD
Journal: Blood
Blood (2013) 122 (21): 1897.
https://doi.org/10.1182/blood.V122.21.1897.1897
Published: 2013
Journal Articles

GMMG MM5 Trial In Newly Diagnosed Multiple Myeloma To Evaluate PAd Vs VCD Induction Prior To High Dose Treatment Followed By Lenalidomide Consolidation and Maintenance – Final Analysis On Induction Therapy

Free
Hartmut Goldschmidt, MD, Jan Duerig, MD, Uta Bertsch, MD, Christina Kunz, PhD, Thomas Hielscher, Mathias Haenel, MD, Igor Wolfgang Blau, MD, PhD, Dirk Hose, Dr. med. dipl.-phys, Anna Jauch, PhD, Baerbel Schurich, PhD, Kai Neben, MD, Anja Seckinger, MD, Barbara Huegle-Doerr, PhD, Maximilian Merz, MD, Markus Munder, MD, Walter Lindemann, MD, Matthias Zeis, MD, Christian Gerecke, MD, Ingo GH Schmidt-Wolf, MD, Katja Weisel, MD, Christof Scheid, MD, Hans Salwender, MD
Journal: Blood
Blood (2013) 122 (21): 3369.
https://doi.org/10.1182/blood.V122.21.3369.3369
Published: 2013
Journal Articles

Prospective Randomized Trial of Len/Dex Induction Followed by Tandem MEL140 with Autologous Blood Stem Cell Transplantation and Len Maintenance Versus Continued Therapy with Len/Dex in Myeloma Patients Age 60–75 Years: Protocol-Defined Safety Analysis After 100 Patients

Free
Christian Straka, Kerstin Schäfer-Eckart, Florian Bassermann, Bernd Hertenstein, Monika Engelhardt, Hans Salwender, MD, Wolf Rösler, Christian Langer, Georgia Schilling, Stefan Knop, Tim H Brümmendorf, Bernd Metzner, Holger Hebart, Albrecht Reichle, Norbert Frickhofen, MD, Else Heidemann, Juliana Ababei, Christian Gerecke, Wolfram Jung, Martin Gramatzki, Thomas Decker, Martin Kropff, MD, Ralph Naumann, Marcus Hentrich, Jochem Walther, Peter Bojko, Tobias Dechow, Hannes Wandt, Axel Hinke, Hermann Einsele
Journal: Blood
Blood (2012) 120 (21): 2012.
https://doi.org/10.1182/blood.V120.21.2012.2012
Published: 2012
Journal Articles

Lenalidomide, adriamycin, and dexamethasone (RAD) in patients with relapsed and refractory multiple myeloma: a report from the German Myeloma Study Group DSMM (Deutsche Studiengruppe Multiples Myelom)

Free
Clinical Trials & Observations
Stefan Knop, Christian Gerecke, Peter Liebisch, Max S. Topp, Uwe Platzbecker, Orhan Sezer, Christina Vollmuth, Karina Falk, Axel Glasmacher, Uwe Maeder, Hermann Einsele, Ralf C. Bargou
Journal: Blood
Blood (2009) 113 (18): 4137–4143.
https://doi.org/10.1182/blood-2008-10-184135
Published: 2009
Journal Articles

Lenalidomide, Adriamycin and Dexamethason (RAD) in Relapsed and Refractory Multiple Myeloma: Final Results from a Phase I/II Trial of “Deutsche Studiengruppe Multiples Myelom”

Free
Christian Gerecke, Stefan Knop, Max S. Topp, Peter Liebisch, Christina Vollmuth, Uwe Platzbecker, Uwe Mäder, Hermann Einsele, Ralf C. Bargou
Journal: Blood
Blood (2008) 112 (11): 2782.
https://doi.org/10.1182/blood.V112.11.2782.2782
Published: 2008
Journal Articles

The Y-box binding protein YB-1 is associated with progressive disease and mediates survival and drug resistance in multiple myeloma

Free
Manik Chatterjee, Christoph Rancso, Thorsten Stühmer, Niels Eckstein, Mindaugas Andrulis, Christian Gerecke, Heike Lorentz, Hans-Dieter Royer, Ralf C. Bargou
Journal: Blood
Blood (2008) 111 (7): 3714–3722.
https://doi.org/10.1182/blood-2007-05-089151
Published: 2008
Includes: Supplemental data
Journal Articles

The Efficacy and Toxicity of the RAD Regimen (Revlimid®, Adriamycin®, Dexamethasone) in Relapsed and Refractory Multiple Myeloma - A Phase I/II Trial of “Deutsche Studiengruppe Multiples Myelom”.

Free
Stefan Knop, Christian Gerecke, Peter Liebisch, Max S. Topp, Georg Hess, Uwe Platzbecker, Sandra Frohnert, Hermann Einsele, Ralf Bargou
Journal: Blood
Blood (2007) 110 (11): 2716.
https://doi.org/10.1182/blood.V110.11.2716.2716
Published: 2007
Journal Articles

Lenalidomide (Revlimid™), Adriamycin and Dexamethasone Chemotherapy (RAD) Is Safe and Effective in Treatment of Relapsed Multiple Myeloma - First Results of a German Multicenter Phase I/II Trial.

Free
Stefan Knop, MD, Christian Gerecke, MD, Max S. Topp, MD, Peter Liebisch, MD, Georg Hess, MD, Sandra Kotkiewitz, Hermann Einsele, MD, Ralf Bargou, MD
Journal: Blood
Blood (2006) 108 (11): 408.
https://doi.org/10.1182/blood.V108.11.408.408
Published: 2006
Journal Articles

Aldehyde Dehydrogenase-Positive Hematopoetic Progenitor Cells in Peripheral Blood and Progenitor Cell Apheresis Products: Characterization and Correlation with Kinetics of Engraftment.

Free
Martin Hildebrandt, MD, Markus Schuler, MD, Kirstin Rautenberg, Christian Gerecke, MD, Wolf-Dieter Ludwig, MD
Journal: Blood
Blood (2005) 106 (11): 1076.
https://doi.org/10.1182/blood.V106.11.1076.1076
Published: 2005
Journal Articles

Nongenotoxic activation of the p53 pathway as a therapeutic strategy for multiple myeloma

Free
Thorsten Stühmer, Manik Chatterjee, Martin Hildebrandt, Pia Herrmann, Hella Gollasch, Christian Gerecke, Sebastian Theurich, Luisa Cigliano, Rudolf A. Manz, Peter T. Daniel, Kurt Bommert, Lyubomir T. Vassilev, Ralf C. Bargou
Journal: Blood
Blood (2005) 106 (10): 3609–3617.
https://doi.org/10.1182/blood-2005-04-1489
Published: 2005